Vascular endothelial growth factor receptor 2 (VEGFR-2), the primary receptor mediating the effects of VEGF-A in cancer, is a key factor of the metastatic cascade, driving tumor angiogenesis, vascular permeability, lymphangiogenesis, and microenvironment remodeling 31-33. This evidence concerns the gene KDR and cancer.